Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 6 studies | 20% ± 5% | |
classical monocyte | 6 studies | 27% ± 11% | |
B cell | 4 studies | 17% ± 1% | |
CD16-negative, CD56-bright natural killer cell, human | 3 studies | 19% ± 3% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 21% ± 5% | |
myeloid cell | 3 studies | 24% ± 7% | |
epithelial cell | 3 studies | 22% ± 8% | |
lymphocyte | 3 studies | 16% ± 0% | |
microglial cell | 3 studies | 21% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 3 studies | 22% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 4740.66 | 577 / 578 | 97% | 9.86 | 1121 / 1155 |
intestine | 84% | 3517.66 | 814 / 966 | 98% | 20.29 | 514 / 527 |
esophagus | 87% | 1657.81 | 1253 / 1445 | 91% | 7.67 | 167 / 183 |
stomach | 82% | 1266.19 | 296 / 359 | 95% | 16.68 | 272 / 286 |
brain | 78% | 4489.78 | 2050 / 2642 | 99% | 8.43 | 700 / 705 |
bladder | 81% | 1604.76 | 17 / 21 | 95% | 14.14 | 481 / 504 |
prostate | 84% | 1580.33 | 206 / 245 | 92% | 4.59 | 462 / 502 |
uterus | 59% | 790.81 | 100 / 170 | 96% | 12.03 | 439 / 459 |
thymus | 59% | 1116.08 | 388 / 653 | 88% | 9.90 | 530 / 605 |
adrenal gland | 82% | 1103.26 | 212 / 258 | 64% | 3.14 | 148 / 230 |
breast | 59% | 990.24 | 269 / 459 | 81% | 5.33 | 902 / 1118 |
kidney | 46% | 811.16 | 41 / 89 | 91% | 6.98 | 817 / 901 |
skin | 33% | 369.78 | 597 / 1809 | 87% | 7.63 | 409 / 472 |
pancreas | 15% | 176.53 | 50 / 328 | 95% | 13.94 | 169 / 178 |
ovary | 30% | 329.86 | 54 / 180 | 78% | 3.55 | 336 / 430 |
liver | 33% | 378.78 | 75 / 226 | 70% | 4.39 | 285 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 82.86 | 29 / 29 |
peripheral blood | 100% | 18324.36 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 16100.75 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.66 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 98% | 12.36 | 44 / 45 |
adipose | 79% | 1247.62 | 952 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 75% | 3.15 | 60 / 80 |
blood vessel | 34% | 521.77 | 452 / 1335 | 0% | 0 | 0 / 0 |
heart | 32% | 364.17 | 273 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 2.03 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0050870 | Biological process | positive regulation of T cell activation |
GO_0042102 | Biological process | positive regulation of T cell proliferation |
GO_0001819 | Biological process | positive regulation of cytokine production |
GO_0030705 | Biological process | cytoskeleton-dependent intracellular transport |
GO_0031122 | Biological process | cytoplasmic microtubule organization |
GO_0042832 | Biological process | defense response to protozoan |
GO_0005813 | Cellular component | centrosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0051959 | Molecular function | dynein light intermediate chain binding |
GO_0005515 | Molecular function | protein binding |
GO_0008017 | Molecular function | microtubule binding |
Gene name | CCDC88B |
Protein name | Coiled-coil domain-containing protein 88B (Brain leucine zipper domain-containing protein) (Gipie) (Hook-related protein 3) (HkRP3) Coiled-coil domain containing 88B |
Synonyms | BRLZ |
Description | FUNCTION: Acts as a positive regulator of T-cell maturation and inflammatory function. Required for several functions of T-cells, in both the CD4(+) and the CD8(+) compartments and this includes expression of cell surface markers of activation, proliferation, and cytokine production in response to specific or non-specific stimulation (By similarity). Enhances NK cell cytotoxicity by positively regulating polarization of microtubule-organizing center (MTOC) to cytotoxic synapse, lytic granule transport along microtubules, and dynein-mediated clustering to MTOC . Interacts with HSPA5 and stabilizes the interaction between HSPA5 and ERN1, leading to suppression of ERN1-induced JNK activation and endoplasmic reticulum stress-induced apoptosis . . |
Accessions | B2RTU8 ENST00000359902.2 H7BY33 ENST00000301897.5 [A6NC98-6] A6NC98 ENST00000356786.10 [A6NC98-1] |